78 new news items in the last 24 hours

23 June 07:30

Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.

Raluca Ioana Draghici

main event image

Economy

www.shutterstock.com

Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.

Sources

Ziarul Financiar

Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei

Business Magazin

Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare

ȘTIRI PE ACELEAȘI SUBIECTE

Economy

Biofarm registered a turnover of 263.2 million lei in the first nine months of 2025, with a net profit of 87.06 million lei, continuing the upward trend.

Economy

Antibiotice Iași has signed a project of 370 million lei for a research and production center for critical medicines, with 52% European funds.

Current Affairs

The Minister of Health, Alexandru Rogobete, emphasized that it is crucial for Romania to strengthen its capacity to produce safe medicines and that it is time to strategically invest in domestic medicine production.

Health

The Ministry of Health invests 29.8 million euros in the first National Center for Research and Production of Advanced Cellular Therapies, dedicated to innovation in oncology.

Current Affairs

Deltamed will launch vehicles capable of transmitting clinical data in real time, improving medical interventions. The company is investing 2.5 million euros in expanding production.

Economy

Antibiotice Iași reported a 52% decrease in net profit in the first nine months of 2025, despite the stabilization of exports and significant investments in development.

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

investment retehnologizare medically research center

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

app preview

google play badge